Post marketing surveillance included in which phase of drug clinical trial?
Surveillance after marketing, i.e. after the drug is out in the market is a pa of Phase IV of clinical trials. It includes follow-up of patients taking the drug and adverse drug reaction (ADR) repoing as well as looking for newer treatment indications Ref: Park 24th edition
i
ii
iii
iv
All India exam